P125 - Is the occurrence of higher adverse effects associated with better oncological outcome in Japanese metastatic urothelial carcinoma patients treated with pembrolizumab?

Publication date: November 2019Source: European Urology Supplements, Volume 18, Issue 11Author(s): N. Hayakawa, E. Kikuchi, K. Ogihara, S. Hattori, S. Yoshimine, S. Shirotake, T. Okabe, R. Yamashita, R. Mizuno, M. Oya
Source: European Urology Supplements - Category: Urology & Nephrology Source Type: research